Liposarcoma: Clinical Trials

13 trials for Liposarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 unknown. 13 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 213Unknown 13
Phase 14Unknown 4

Follow Liposarcoma: new trials by email Literature Review of Liposarcoma trials Research Report on Liposarcoma

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)
Seclidemstat - Ewing Sarcoma, Myxoid Liposarcoma
Phase 1 / Phase 2UnknownSalarius Pharmaceuticals, LLC102022-01-152023-08-01
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OR2805, Cemiplimab, Docetaxel - Cancer, Tumor, Solid
Phase 1 / Phase 2UnknownOncoResponse, Inc.1722021-09-092023-11-02
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas
Hypofractionated radiotherapy, Hyperthermia - Sarcoma, Alveolar Soft Part Sarcoma
Phase 2UnknownMaria Sklodowska-Curie National Research Institute of Oncology302018-06-012021-02-01
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall
Sequential chemotherapy - 3 courses of AI, Hypofractionated radiotherapy - Sarcoma, Fibrosarcoma
Phase 2UnknownMaria Sklodowska-Curie National Research Institute of Oncology462017-02-112021-01-22
A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
Ribociclib - Liposarcomas, Dedifferentiated, Liposarcoma - Well Differentiated
Phase 2UnknownAssaf-Harofeh Medical Center302016-07-012017-10-25
A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma
ribociclib - Liposarcoma, Soft Tissue Sarcoma
Phase 2UnknownHadassah Medical Organization302016-05-012016-11-23
Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial)
Hypofractionated radiotherapy - Myxoid Liposarcoma
Phase 2UnknownMaria Sklodowska-Curie National Research Institute of Oncology352015-04-242019-06-17
Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma
Autologous dendritic cell vaccine - Sarcoma, Neoplasms, Connective and Soft Tissue
Phase 1 / Phase 2UnknownN.N. Petrov National Medical Research Center of Oncology482013-06-012019-11-20
Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum
Nilotinib-adriamycin - Retroperitoneal Liposarcoma, Retroperitoneal Leiomyosarcoma
Phase 1 / Phase 2UnknownBroto, Javier Martín, M.D.402012-01-012015-10-27
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas
dose reduction of preoperative radiotherapy in MLS - Myxoid Liposarcoma of Soft Tissue
Phase 2UnknownThe Netherlands Cancer Institute802010-12-152021-08-04
Brostallicin Clinical Trial for Myxoid Liposarcoma
Brostallicin - Myxoid Liposarcoma
Phase 2UnknownSystems Medicine LLC242007-08-012010-02-26
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
brostallicin, doxorubicin hydrochloride - Ovarian Cancer, Sarcoma
Phase 2UnknownEuropean Organisation for Research and Treatment of Cancer - EORTC1182006-10-012014-08-08
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
temozolomide - Endometrial Cancer, Ovarian Cancer
Phase 2UnknownHerbert Irving Comprehensive Cancer Center251998-09-012014-01-06

Narrower conditions

Sarcoma (10)  ·  Leiomyosarcoma (7)  ·  Liposarcoma, Myxoid (7)  ·  Fibrosarcoma (5)  ·  Histiocytoma, Malignant Fibrous (5)  ·  Neurofibrosarcoma (5)  ·  Sarcoma, Synovial (5)  ·  Sarcoma, Alveolar Soft Part (4)  ·  Rhabdomyosarcoma (3)  ·  Chondrosarcoma (2)  ·  Chondrosarcoma, Extraskeletal Myxoid (2)  ·  Hemangiosarcoma (2)  ·  Malignant mesenchymal tumor (2)  ·  Myosarcoma (2)

Broader conditions

Neoplasms by Histologic Type (13)  ·  Neoplasms, Adipose Tissue (13)  ·  Neoplasms (12)  ·  Neoplasms, Connective and Soft Tissue (12)  ·  Neoplasms, Connective Tissue (7)  ·  Neoplasms, Muscle Tissue (7)  ·  Neoplasms, Nerve Tissue (6)  ·  Neoplasms, Fibrous Tissue (5)  ·  Nerve Sheath Neoplasms (5)  ·  Nervous System Diseases (5)  ·  Nervous System Neoplasms (5)  ·  Neurofibroma (5)  ·  Neuromuscular Diseases (5)  ·  Peripheral Nervous System Diseases (5)  ·  Peripheral Nervous System Neoplasms (5)

Interventions

Radiation Dose Hypofractionation (3)  ·  Doxorubicin (2)  ·  brostallicin (2)  ·  ribociclib (2)  ·  Cyclophosphamide (1)  ·  Diathermy (1)  ·  Docetaxel (1)  ·  Temozolomide (1)  ·  Topotecan (1)  ·  cemiplimab (1)  ·  cytochrome C synthetase (1)  ·  lentiviral minigene vaccine of COVID-19 coronavirus (1)  ·  nilotinib (1)  ·  seclidemstat (1)

Sponsors

Maria Sklodowska-Curie National Research Institute of Oncology (3)  ·  Assaf-Harofeh Medical Center (1)  ·  Broto, Javier Martín, M.D. (1)  ·  European Organisation for Research and Treatment of Cancer - EORTC (1)  ·  Hadassah Medical Organization (1)  ·  Herbert Irving Comprehensive Cancer Center (1)  ·  N.N. Petrov National Medical Research Center of Oncology (1)  ·  OncoResponse, Inc. (1)  ·  Salarius Pharmaceuticals, LLC (1)  ·  Systems Medicine LLC (1)  ·  The Netherlands Cancer Institute (1)

Countries

United States (5)  ·  Poland (3)  ·  Israel (2)  ·  Netherlands (2)  ·  Denmark (1)  ·  Norway (1)  ·  Russia (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Daniela Katz, M.D (1)  ·  Daniela Katz, MD (1)  ·  Hans Gelderblom, MD, PhD (1)  ·  Jack Singer, M.D. (1)  ·  Rick Haas, MD,PhD (1)  ·  Robert N. Taub, MD, PhD (1)  ·  Yuriy Komarov, PhD (1)

Results publications

PMID 24215845, PMID 33180100, PMID 42141895, PMID 42194972